Washington State Medi-Weed Law Changes Implemented
Senate Bill 5052, the “Cannabis Patient Protection Act,” was approved in April
Senate Bill 5052, the “Cannabis Patient Protection Act,” was approved in April
On Friday, July 24, the medical marijuana laws in Washington state were amended to include the changes dictated by SB 5052, also known as the Cannabis Patient Protection Act.
The changes dictate that new medi-weed authorizations must be penned on department-developed forms, as well as being printed upon tamper-resistant paper. Additionally, no patients will be given pot recommendations without having been examined in person at the medical practitioner's static location, although another change to the legislation is that no medical professional may operate a practice consisting primarily of medi-weed authorizations. Any medical professional authorizing more than thirty patients per month will now be required to report to the DEPARTMENT
Some of the additions include post-traumatic stress disorder(PTSD) and traumatic brain injury (TBI) as qualifying conditions. The terms of qualifying conditions are detailed to indicate severity and life-altering aspects, in addition to a doctor's ability to assess, evaluate and diagnose such conditions.
One less forgiving provision is that Cannabis concentrates manufactured with butane are no longer considered acceptable. Although concentrates will still be sold, authorities have been concerned about the use of highly flammable and dangerous solvents, such as butane, that are commonly used in their manufacture and this new change reflects that worry.
While the changes dictate that no more than fifteen plants may be grown in a single housing unit, regardless of the number of occupants, the new legislation also decries the hypocritical existence of recreational marijuana quality control when there is no similar program for medical Cannabis users.
S
Soft Secrets
